Unclaimed Scholar Profile
Are you David B. Meya? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Makerere UniversityASIDASID-6387-9483-4758 orcid.org/0000-0002-8854-0321
David B. Meya
Makerere University•Uganda
Faculty researcher at Makerere University, specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities]
#Fungal Infections and Studies#Infectious Diseases and Tuberculosis#Bacterial Infections and Vaccines
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 10,362 | 2,721 |
| h-index | 49 | 34 |
| i10-index | 172 | 103 |
Annual Citation Growth
Verified Citations / Year0
2020272
2021+40%381
2022+29%490
2023+33%653
2024-8%599
2025-45%327
2026Scholarship Distribution & Proportions356 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (8,497) • 18% Global Research Impact (1,865)
356 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
2Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (356)
Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast
Published in Emerging infectious diseases•2013
DOI: 10.3201/eid2001.130906 Verified Peer-Reviewed
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study
Published in The Lancet Infectious Diseases•2017
DOI: 10.1016/s1473-3099(17)30474-7 Verified Peer-Reviewed
Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy
DOI: 10.1086/587667 Verified Peer-Reviewed
Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings
DOI: 10.1086/655143 Verified Peer-Reviewed
Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study
Published in PLoS Medicine•2010
DOI: 10.1371/journal.pmed.1000384 Verified Peer-Reviewed
Showing 1 – 5 of 356 publications
1 / 72